Suvorexant Patent Expiration

Suvorexant is Used for promoting sleep and treating insomnia. It was first introduced by Merck Sharp And Dohme Corp in its drug Belsomra on Aug 13, 2014.

Suvorexant Patents

Given below is the list of patents protecting Suvorexant, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Belsomra US10098892 Solid dosage formulations of an orexin receptor antagonist May 29, 2033 Merck Sharp Dohme
Belsomra US7951797 Substituted diazepan orexin receptor antagonists Nov 20, 2029 Merck Sharp Dohme

Coming Soon

Patent Strength Analyzer

Will this be useful for you?


Thank you for your response 🥳